Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6804193 | Neurobiology of Aging | 2018 | 6 Pages |
Abstract
Cerebrospinal fluid YKL-40 has been described as a marker of glial inflammation. We aimed to study the relationship between YKL-40 and brain structure and its interactions with core Alzheimer's disease (AD) biomarkers. We measured cortical thickness (CTh) and cerebrospinal fluid biomarkers (amyloid-β 1-42 [Aβ42], total tau, p-tau, and YKL-40) of 80 cognitively normal controls and 27 patients with amnestic mild cognitive impairment. Subjects were classified as Aβ42+ (<550 pg/mL) or Aβ42â (>550 pg/mL). CTh difference maps were derived from the interaction and correlation analyses in the whole sample and within clinical groups. There was a strong correlation between YKL-40 and markers of neurodegeneration (total tau and p-tau). In the whole sample, we found a negative correlation between YKL-40 and CTh in AD vulnerable areas in Aβ42+ subjects but not in Aβ42 participants. Our results suggest that YKL-40 could track the inflammatory processes associated to tau-related neurodegeneration in the presence of the AD pathophysiological process.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Daniel Alcolea, Eduard Vilaplana, Jordi Pegueroles, Victor Montal, Pascual Sánchez-Juan, Andrea González-Suárez, Ana Pozueta, Eloy RodrÃguez-RodrÃguez, David Bartrés-Faz, DÃdac Vidal-Piñeiro, SofÃa González-Ortiz, Santiago Medrano,